Based on powerful epidemiological data such as numbers
afflicted, mortality rates from suicide, personal and familial
consequences, and skyrocketing fiscal costs, major depressive
disorder (MDD) has the sad and ignominious distinction of being a
leader among disabling disorders worldwide.
With lifetime prevalence risks of 13% for men and 21% for women,
the magnitude of this crisis cannot be understated. This
hard-hitting volume focuses on recurrences -- perhaps most
important among the many factors (others include extreme
underdiagnosis and undertreatment, genetic vulnerability, frequent
recurrences, severe stigma and poor adherence with maintenance
treatment, and brain tissue degenerative changes associated with
recurrences and chronic depression) that contribute to MDD's high
morbidity.
Following an introduction by the editor detailing the
overwhelming personal and societal burden created by MDD, the
distinguished authors of this volume emphasize five critical
topics: - The lifetime impact of gender on recurrent MDD in women,
emphasizing the clinical features, treatment, and prevention
strategies of the illness during three key periods of hormone
transition (adolescence, childbearing years, and middle life) and
including recommendations on where future research should focus.-
Treatment strategies for chronic and recurrent depression to help
prevent acute episodes from developing into long-term depression,
specifically addressing the continuing question of whether
pharmacotherapy and psychotherapy combinations are superior to
either alone.- Prevention of recurrences in bipolar patients,
updating the demonstrated benefits of several new anticonvulsant
mood stabilizers and integrative treatment approaches and
suggesting that treatment success depends on a multifaceted
approach that combines old and new pharmacotherapy.- Potential
applications of new somatic treatment strategies involving
minimally invasive brain stimulation that have greatly reduced the
stigma but done little to advance the diagnosis and treatment of
neuropsychiatric illnesses, with exciting data suggesting the
efficacy of vagal nerve stimulation (VNS) and repetitive
transcranial magnetic stimulation (TMS).- A "call to arms" with
updated recommendations on how to ensure demonstrable, lasting
progress in preventing recurrences of depression, which -- along
with other chronic diseases such as diabetes, heart disease, and
schizophrenia -- progresses throughout life unless actively
treated.
This highly informative volume, clearly written and
exceptionally well referenced, is a "must-read" for every
clinician, including specialists in depression and clinical
neurosciences, primary care physicians and mental health clinicians
interested in learning more about how to successfully treat what
remains one of our most recalcitrant, debilitating illnesses.
General
Imprint: |
American Psychiatric Publishing Inc
|
Country of origin: |
United States |
Release date: |
June 2001 |
First published: |
May 2001 |
Editors: |
John F. Greden
|
Series editors: |
John M. Oldham
(Professor and Interim ChairBarbara and Corbin Robertson Jr. Endowed Chair for Personality Disorders)
• Michelle B. Riba
|
Dimensions: |
229 x 152 x 13mm (L x W x T) |
Format: |
Paperback
|
Pages: |
214 |
ISBN-13: |
978-1-58562-025-8 |
Categories: |
Books
Promotions
|
LSN: |
1-58562-025-4 |
Barcode: |
9781585620258 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!